Luke Bagaason - Profile and Investment Details

Investor Profile

Luke Bagaason is a Venture Capital, Incubator, Accelerator, Private Equity Firm, Investor based in Denver, Colorado, United States with a diverse investment portfolio that includes companies such as AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology, Jounce Therapeutics, Wave Life Sciences, LifeMine Therapeutics, Peloton Therapeutics10X Genomics, Ardelyx, Adaptimmune, Cullinan Oncology, Kira Pharmaceuticals, Generation Bio, Relay Therapeutics, Protagonist Therapeutics, Decibel Therapeutics, Alector, Cue, Orchard Therapeutics, Crossover Health, Audentes Therapeutics, Tarsa Therapeutics, Verona Pharma, Aduro BioTech, Juvenescence, Genomics, Intarcia Therapeutics, Turning Point Therapeutics, Akari Therapeutics, Genapsys, Cerevance, SomaLogic, Bit Bio, Affinivax, Fulcrum Therapeutics, Inscripta, Intellia Therapeutics, Maze Therapeutics, Replimune Group, ALX Oncology, WaveTec Vision, Tempest Therapeutics, evonetix, HealthVerity, ORIC Pharmaceuticals, EverlyWell, Tasso, Vaxcyte, Delfi Diagnostics, Sequenta, REGENXBIO, Solid Biosciences, Keros Therapeutics, Nexvet, Venatorx Pharmaceuticals, Insitro, VelosBio, Mindstrong, Kinnate Biopharma, Kriya Therapeutics, Twist Bioscience, Aimmune Therapeutics, Element Biosciences, Pharvaris, Arcus Biosciences, DNAnexus, Nurix Therapeutics, Ivantis, SAGE Therapeutics, . Over time, Luke Bagaason has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Luke Bagaason is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Data Science, Wellness, Women Founded, Enterprise Software, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Analytics, Software, Biotechnology, Consumer Health, Medical Devices, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Productivity Software, Precision Medicine, Consumer Software, Gene Therapy, Personalized Medicine, Health Diagnostics, Digital Health, Travel, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Pharmaceuticals, Spatial Biology, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Luke Bagaason, as their portfolio suggests a familiarity and interest in this area.

Understanding Luke Bagaason’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.